NARA Discovery
Article Details
← Back to Search Results
Journal Article

Circular RNA expression profile of systemic lupus erythematosus and its clinical significance as a potential novel biomarker

Wenyu Li; Runge Fan; Cheng Zhou; Yue Wei; Shunsheng Lin; Sijian Wen; Wen Zeng; Wei Hou; Cheng Zhao; Youkun Lin
Genes & Genomics · Vol. 44, Issue 11 · pp. 1405-1414 · 2022

Abstract

Background Circular RNAs (circRNAs) are a class of endogenous noncoding RNAs that are more abundant, specific, and highly organized than linear RNAs. Increasing evidence supports that circRNAs may serve as diagnostic biomarkers in many diseases, but their potential as biomarkers in systemic lupus erythematosus (SLE) remains unclear. Objective We investigated the critical circRNAs involved in SLE progression and explored their potential application as biomarkers in SLE. Method RNA sequencing was conducted on peripheral blood mononuclear cells (PBMCs) from 4 SLE patients and 4 healthy volunteers. CircRNA profile data were analyzed to identify differentially expressed circRNAs and visualized via R software. After screening, qPCR analysis of target circRNA expression was performed using PBMCs from 31 SLE patients and 35 healthy volunteers. Correlations between circRNA expression levels and the SLEDAI score were assessed via Spearman correlation analysis. Finally, the performance of circRNAs as biomarkers in SLE was examined by receiver operating characteristic curve analysis. Results The result identified six differentially expressed circRNAs between SLE patients and healthy controls: hsa_circ_0006689, hsa_circ_0070562, hsa_circ_0006117, hsa_circ_0007683, hsa_circ_0042519, and hsa_circ_0008647. The validation analysis showed differing relative expression levels of hsa_circ_0007683, hsa_circ_0042519, hsa_circ_0008647, and hsa_circ_0006689 between SLE patients and healthy volunteers (P < 0.05), and hsa_circ_0006689 expression in PBMCs correlated with the SLEDAI score (P < 0.05). Furthermore, addition of hsa_circ_0006689 expression increased the sensitivities of anti-dsDNA antibody and anti-Sm antibody levels for SLE diagnosis (from 29.03 to 61.30% and 32.26–71.00%, respectively). Conclusion Our results suggest hsa_circ_0006689 may be a useful circRNA biomarker for SLE diagnosis and prognosis.

Bibliographic Information

JournalGenes & Genomics
PublisherSpringer
Publication Date2022-11-01
Publication Year2022
Volume44
Issue11
Pages1405-1414
Document TypeJournal Article
Print ISSN1976-9571
eISSN2092-9293
DOI10.1007/s13258-022-01315-z

Access Information

NARA Access Coverage2009-01-01~Current
Journal Homepagehttps://www.springer.com/journal/13258
Publisher PageOpen Publisher Page
Full-text access depends on NARA's subscribed coverage and institutional access.